Simian b2M(Beta-2-Microglobulin) ELISA Kit
(B2M/961) Antibody) Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC940961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF594 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC940961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF594 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC700961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF770 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC700961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF770 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC880961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF488A conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC880961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF488A conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC050961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405M conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC050961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405M conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC040961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405S conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC040961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF405S conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC400961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF640R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC400961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF640R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCB0961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Biotin conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCB0961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Biotin conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCAP0961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCAP0961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCA0961-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), APC conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCR0961-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), RPE conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCP0961-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), PerCP conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNUM0961-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), 1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCH0961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNCH0961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNUB0961-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Concentration: 0.2mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNUB0961-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), Concentration: 0.2mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC610961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF660R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC610961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF660R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC550961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF555 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC550961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF555 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC430961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF543 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC430961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF543 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC680961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF568 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC680961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF568 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC470961-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF647 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(B2M/961) Antibody |
|
BNC470961-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(B2M/961), CF647 conjugate, Concentration: 0.1mg/mL |
 B2M Beta-2 Microglobulin Human protein |
|
PROTP61769-1 |
BosterBio |
Regular: 1mg |
EUR 380.4 |
|
Description: Human Beta-2 Microglobulin produced in Human urine from patients with tubular proteinuria having a molecular mass of 12KDa and pI of 5.6. |
 High Pure (>98%)) Beta 2 Microglobulin (B2M) High Pure (>98%) |
|
B2M16-N-1 |
Alpha Diagnostics |
1 mg |
EUR 489.6 |
 beta 2 Microglobulin ELISA kit |
|
55R-ORG5BM |
Fitzgerald |
96 wells |
EUR 411.6 |
|
Description: ELISA kit for the detection of beta 2 Microglobulin in the research laboratory |
 Human beta 2-Microglobulin, B2M Protein |
|
20-abx060123 |
Abbexa |
|
|
|
|
Human beta 2-Microglobulin, B2M Protein |
|
abx060235-1mg |
Abbexa |
1 mg |
EUR 878.4 |
|
|
Human beta 2-Microglobulin, B2M Protein |
|
abx060262-1mg |
Abbexa |
1 mg |
EUR 1128 |
|
|
 Protein) Human beta 2-Microglobulin (B2M) Protein |
|
abx670062-1mg |
Abbexa |
1 mg |
EUR 510 |
|
|
Human beta 2-Microglobulin (B2M) Protein |
|
abx670198-1mg |
Abbexa |
1 mg |
EUR 560.4 |
|
|
Human beta 2-Microglobulin (B2M) Protein |
|
abx670241-1mg |
Abbexa |
1 mg |
EUR 444 |
|
|
(BBM.1) Antibody) Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCA0142-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), APC conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC800142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC800142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC810142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC810142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF680R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC940142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF594 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC940142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF594 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC700142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF770 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC700142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF770 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC880142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF488A conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC880142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF488A conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC430142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF543 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC430142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF543 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC400142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF640R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC400142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF640R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC050142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405M conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC050142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405M conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCAP0142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCAP0142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCB0142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Biotin conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCB0142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Biotin conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCR0142-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), RPE conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNUB0142-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Concentration: 0.2mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNUB0142-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Concentration: 0.2mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCP0142-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), PerCP conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNUM0142-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), 1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCH0142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNCH0142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC040142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405S conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC040142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF405S conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC550142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF555 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC550142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF555 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC610142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF660R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC610142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF660R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC680142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF568 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC680142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF568 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC470142-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF647 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (B2M)(BBM.1) Antibody |
|
BNC470142-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (B2M)(BBM.1), CF647 conjugate, Concentration: 0.1mg/mL |
 B2M Beta 2 Microglobulin Human Recombinant Protein |
|
PROTP61769 |
BosterBio |
Regular: 50ug |
EUR 380.4 |
|
Description: B2 Microglobulin Human Recombinant produced in E.Coli is a non-glycosylated polypeptide chain having a molecular mass of 11.76 kDa.;The B2M is purified by proprietary chromatographic techniques. |
 Human beta 2 Microglobulin ELISA kit |
|
55R-2051 |
Fitzgerald |
96 tests |
EUR 854.4 |
|
Description: ELISA Kit for detection of beta 2 Microglobulin in the research laboratory |
 Human Beta 2 Microglobulin ELISA Kit |
|
PRB-5038 |
Cell Biolabs |
96 assays |
EUR 686.4 |
|
Description: Our Human Beta 2 Microglobulin ELISA Kit is a sandwich ELISA for the detection of human beta 2 microglobulin in plasma, serum, lysates, and other biological fluids. Samples or standards are added to an anti-b2M antibody coated plate followed by the addition of an HRP conjugated anti-human b2M antibody. The absorbance is read at 450nm and the level of b2M in samples is determined based on the provided human b2M standard curve. |
 Partially Pure (40-90%)) Beta 2 Microglobulin (B2M) Partially Pure (40-90%) |
|
B2M17-N-1 |
Alpha Diagnostics |
1 mg |
EUR 343.2 |
 RealScreen Beta 2 Microglobulin ELISA Kit |
|
EL065-096 |
GenDepot |
96T |
EUR 1161.6 |
) Polyclonal B2M / Beta 2 Microglobulin Antibody (C-Terminus) |
|
APR03270G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human B2M / Beta 2 Microglobulin (C-Terminus). This antibody is tested and proven to work in the following applications: |
 protein for ELISA/Standards) Purified Human beta-2 microglobulin (B2M) protein for ELISA/Standards |
|
B2M15-N |
Alpha Diagnostics |
50 ug |
EUR 343.2 |
 (OKIA00134)) beta-2 Microglobulin ELISA Kit (Rat) (OKIA00134) |
|
OKIA00134 |
Aviva Systems Biology |
96 Wells |
EUR 810 |
|
Description: Description of target: Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. ;Species reactivity: Rat;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.835 ng/ml |
 WB +ve control) Purified Human beta-2 microglobulin (B2M) WB +ve control |
|
B2M11-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
 Anti-Beta 2 Microglobulin/B2M Antibody |
|
A00456-1 |
BosterBio |
100ug/vial |
EUR 400.8 |
 Anti-beta 2 Microglobulin/B2m Antibody |
|
A00456-2 |
BosterBio |
100ug/vial |
EUR 352.8 |
Anti-beta 2 Microglobulin/B2m Antibody |
|
A00456-3 |
BosterBio |
100ug/vial |
EUR 352.8 |
 ascites) Monoclonal Anti-Human beta-2 microglobulin (B2M) ascites |
|
B2M12-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
 Beta 2 Microglobulin |
|
PR27237 |
Neuromics |
50 ug |
EUR 381.6 |
 IgG, aff pure) Goat Anti-Human beta-2 microglobulin (B2M) IgG, aff pure |
|
B2M13-A |
Alpha Diagnostics |
100 ug |
EUR 578.4 |
 antiserum # 1) Rabbit Anti-Human beta-2 microglobulin (B2M) antiserum # 1 |
|
B2M11-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
) Anti-Beta-2 Microglobulin Antibody (B2M/961) |
|
A1440-100 |
Biovision |
each |
EUR 574.8 |
 (OKIA00054)) beta 2-Microglobulin ELISA Kit (Human) (OKIA00054) |
|
OKIA00054 |
Aviva Systems Biology |
96 Wells |
EUR 621.6 |
|
Description: Description of target: Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. Exogenously applied M.tuberculosis EsxA or EsxA-EsxB (or EsxA expressed in host) binds B2M and decreases its export to the cell surface (total protein levels do not change), probably leading to defects in class I antigen presentation.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.822 ng/ml |
 Human Beta-2 Microglobulin OneStep ELISA Kit |
|
EK7023 |
BosterBio |
96wells/kit, with removable strips. |
EUR 573.6 |
 (B2M/1857R) Antibody) Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC941857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF594 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC941857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF594 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC801857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC801857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC701857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF770 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC701857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF770 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC881857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF488A conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC881857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF488A conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC811857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC811857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF680R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC051857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405M conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC051857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405M conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC041857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405S conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC041857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF405S conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC401857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF640R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC401857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF640R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCAP1857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCAP1857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCA1857-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), APC conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCP1857-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), PerCP conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCR1857-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), RPE conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCH1857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCH1857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCB1857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Biotin conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNCB1857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Biotin conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNUB1857-100 |
Biotium |
100uL |
EUR 316.8 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Concentration: 0.2mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNUB1857-50 |
Biotium |
50uL |
EUR 486 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), 1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNUB1857-500 |
Biotium |
500uL |
EUR 615.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), Concentration: 0.2mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC471857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF647 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC471857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF647 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC611857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF660R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC611857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF660R conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC431857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF543 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC431857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF543 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC551857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF555 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC551857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF555 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC681857-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF568 conjugate, Concentration: 0.1mg/mL |
Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R) Antibody |
|
BNC681857-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/1857R), CF568 conjugate, Concentration: 0.1mg/mL |
 (B2M/961) Antibody) Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/961) Antibody |
|
BNUB0961-50 |
Biotium |
50uL |
EUR 486 |
|
Description: Primary antibody against Beta-2 Microglobulin (Renal Failure & Tumor Marker) (B2M/961), 1mg/mL |
 B2M Human, Beta 2 Microglobulin Human Recombinant Protein, His Tag |
|
PROTP61769-2 |
BosterBio |
Regular: 5ug |
EUR 380.4 |
|
Description: B2M Recombinant Human produced in E.Coli is a single, non-glycosylated polypeptide chain containing 120 amino acids (1-119 a.a.) and having a molecular mass of 14 kDa. The B2M is fused to a 21 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. |
 beta 2 Microglobulin protein |
|
30R-3114 |
Fitzgerald |
1 mg |
EUR 1066.8 |
|
Description: Purified native beta 2 Microglobulin protein |
beta 2 Microglobulin protein |
|
30R-3197 |
Fitzgerald |
50 ug |
EUR 308.4 |
|
Description: Purified recombinant beta 2 Microglobulin protein |
beta 2 Microglobulin protein |
|
30-1359 |
Fitzgerald |
500 ug |
EUR 418.8 |
|
Description: Purified recombinant beta 2 Microglobulin protein |
 beta 2 Microglobulin Protein |
|
abx061021-1mg |
Abbexa |
1 mg |
EUR 493.2 |
|
|
 beta 2 Microglobulin antibody |
|
10-1560 |
Fitzgerald |
1 mg |
EUR 470.4 |
|
Description: Mouse monoclonal beta 2 Microglobulin antibody |
beta 2 Microglobulin antibody |
|
10-1561 |
Fitzgerald |
1 mg |
EUR 470.4 |
|
Description: Mouse monoclonal beta 2 Microglobulin antibody |
beta 2 Microglobulin antibody |
|
10-1934 |
Fitzgerald |
200 ul |
EUR 651.6 |
|
Description: Mouse monoclonal beta 2 Microglobulin antibody |
beta 2 Microglobulin antibody |
|
20R-MR013 |
Fitzgerald |
100 µg |
EUR 796.8 |
|
Description: Rabbit polyclonal beta 2 Microglobulin antibody |
beta 2 Microglobulin antibody |
|
20C-CR2010SP |
Fitzgerald |
1 ml |
EUR 439.2 |
|
Description: Sheep polyclonal beta 2 Microglobin antibody |
beta 2 Microglobulin antibody |
|
20-MS30 |
Fitzgerald |
1 ml |
EUR 457.2 |
|
Description: Sheep polyclonal beta 2 Microglobulin antibody |
 Beta 2 Microglobulin Antibody |
|
abx024163-10mg |
Abbexa |
10 mg |
EUR 910.8 |
|
|
beta 2 Microglobulin antibody |
|
70R-5904 |
Fitzgerald |
50 ug |
EUR 560.4 |
|
Description: Rabbit polyclonal beta 2 Microglobulin antibody raised against the N terminal of B2M |
 Beta 2 Microglobulin antibody |
|
70R-7564 |
Fitzgerald |
1 mg |
EUR 386.4 |
|
Description: Affinity purified Goat polyclonal Beta 2 Microglobulin antibody |
 beta 2 Microglobulin Antibody |
|
35366-100ul |
SAB |
100ul |
EUR 468 |
beta 2 Microglobulin Antibody |
|
48829-100ul |
SAB |
100ul |
EUR 399.6 |
beta 2 Microglobulin Antibody |
|
48829-50ul |
SAB |
50ul |
EUR 286.8 |
 Mouse Beta-2 microglobulin ELISA Kit, 96 tests, Quantitative |
|
9245 |
Alpha Diagnostics |
1 Kit |
EUR 927.6 |
; Clone B2M/1118 (Concentrate)) Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/1118 (Concentrate) |
|
RA0424-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 360 |
 Beta-2 Microglobulin Antibody |
|
48016-100ul |
SAB |
100ul |
EUR 399.6 |
Beta-2 Microglobulin Antibody |
|
48016-50ul |
SAB |
50ul |
EUR 286.8 |
Beta-2 Microglobulin Antibody |
|
RQ4629 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: Beta-2 microglobulin also known as B2M is a component of MHC class I molecules, which are present on all nucleated cells (excludes red blood cells). In humans, the beta-2-microglobulin protein is encoded by the B2M gene. The protein has a predominantly beta-pleated sheet structure that can form amyloid fibrils in some pathological conditions. The encoded antimicrobial protein displays antibacterial activity in amniotic fluid. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia. |
Beta-2 Microglobulin Antibody |
|
V3538-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3538-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3538IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3538SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3539-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3539-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3539IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3539SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V3704-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V3704-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V3704IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V3704SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V7123-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V7123-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V7123IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V7123SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Beta-2 Microglobulin/B2M is a component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system. [UniProt] |
Beta-2 Microglobulin Antibody |
|
V2800-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2800-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2800IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2800SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2801-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
Beta-2 Microglobulin Antibody |
|
V2801-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
Beta-2 Microglobulin Antibody |
|
V2801IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
Beta-2 Microglobulin Antibody |
|
V2801SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Serum Beta-2 Microglobulin (B2M) levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. |
Beta-2 Microglobulin Antibody |
|
V2802-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha- heavy chain that contains three subdomains (alpha-1, alpha-2, alpha-3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha-3 subdomain of the alpha- heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha-1 and alpha-2 domains of the alpha- heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V2802-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 12kDa, identified as microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha- heavy chain that contains three subdomains (alpha-1, alpha-2, alpha-3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha-3 subdomain of the alpha- heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha-1 and alpha-2 domains of the alpha- heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V2802SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha- heavy chain that contains three subdomains (alpha-1, alpha-2, alpha-3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha-3 subdomain of the alpha- heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha-1 and alpha-2 domains of the alpha- heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V2803-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: The antibody recognizes the hidden determinant of beta-2 microglobulin (i.e. binding to its determinant is available only when the chain is separated from the HLA heavy chain). Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2803-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: The antibody recognizes the hidden determinant of beta-2 microglobulin (i.e. binding to its determinant is available only when the chain is separated from the HLA heavy chain). Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2803SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: The antibody recognizes the hidden determinant of beta-2 microglobulin (i.e. binding to its determinant is available only when the chain is separated from the HLA heavy chain). Beta-2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta-2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta-2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). |
Beta-2 Microglobulin Antibody |
|
V2804-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V2804-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V2804IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
Beta-2 Microglobulin Antibody |
|
V2804SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a protein of 12kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes. |
; Clone B2M/961 (Concentrate)) Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Concentrate) |
|
RA0425-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 150 |
Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Concentrate) |
|
RA0425-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 360 |
 beta 2 Microglobulin Rabbit mAb |
|
A11642 |
Abclonal |
20 μL |
EUR 18 |
beta 2 Microglobulin Rabbit mAb |
|
A11642-100ul |
Abclonal |
100 ul |
EUR 492 |
beta 2 Microglobulin Rabbit mAb |
|
A11642-200ul |
Abclonal |
200 ul |
EUR 685.2 |
beta 2 Microglobulin Rabbit mAb |
|
A11642-20ul |
Abclonal |
20 ul |
EUR 265.2 |
beta 2 Microglobulin Rabbit mAb |
|
A11642-50ul |
Abclonal |
50 ul |
EUR 344.4 |
 beta 2 Microglobulin Rabbit pAb |
|
A1562-100ul |
Abclonal |
100 ul |
EUR 369.6 |
beta 2 Microglobulin Rabbit pAb |
|
A1562-200ul |
Abclonal |
200 ul |
EUR 550.8 |
beta 2 Microglobulin Rabbit pAb |
|
A1562-20ul |
Abclonal |
20 ul |
EUR 219.6 |
beta 2 Microglobulin Rabbit pAb |
|
A1562-50ul |
Abclonal |
50 ul |
EUR 267.6 |
 Beta 2 Microglobulin, Human Urine |
|
P1432-100 |
Biovision |
each |
EUR 183.6 |
Beta 2 Microglobulin, Human Urine |
|
P1432-250 |
Biovision |
each |
EUR 248.4 |
Simian b2M(Beta-2-Microglobulin) ELISA Kit